Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Onswik
Published 1 month, 3 weeks ago
Description
InnoCare Pharma and Eli Lilly ink a multibillion-dollar research collaboration, FDA approves Lilly's once-weekly insulin Onswik for type 2 diabetes, and Jen Lamppa talks fixing clinical trial patient enrollment with real-world data.